|International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma|
WD Travis, E Brambilla, M Noguchi, AG Nicholson, KR Geisinger, ...
Journal of thoracic oncology 6 (2), 244-285, 2011
|Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label …|
T Mitsudomi, S Morita, Y Yatabe, S Negoro, I Okamoto, J Tsurutani, T Seto, ...
The lancet oncology 11 (2), 121-128, 2010
|The 2015 World Health Organization classification of lung tumors: impact of genetic, clinical and radiologic advances since the 2004 classification|
WD Travis, E Brambilla, AG Nicholson, Y Yatabe, JHM Austin, ...
Journal of thoracic oncology 10 (9), 1243-1260, 2015
|Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival|
J Takamizawa, H Konishi, K Yanagisawa, S Tomida, H Osada, H Endoh, ...
Cancer research 64 (11), 3753-3756, 2004
|A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation|
Y Hayashita, H Osada, Y Tatematsu, H Yamada, K Yanagisawa, ...
Cancer research 65 (21), 9628-9632, 2005
|Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications|
T Kosaka, Y Yatabe, H Endoh, H Kuwano, T Takahashi, T Mitsudomi
Cancer research 64 (24), 8919-8923, 2004
|Comprehensive genomic profiles of small cell lung cancer|
J George, JS Lim, SJ Jang, Y Cun, L Ozretić, G Kong, F Leenders, X Lu, ...
Nature 524 (7563), 47-53, 2015
|EML4-ALK mutations in lung cancer that confer resistance to ALK inhibitors|
YL Choi, M Soda, Y Yamashita, T Ueno, J Takashima, T Nakajima, ...
New England Journal of Medicine 363 (18), 1734-1739, 2010
|Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non–small-cell lung cancer with postoperative …|
T Mitsudomi, T Kosaka, H Endoh, Y Horio, T Hida, S Mori, S Hatooka, ...
Journal of Clinical Oncology 23 (11), 2513-2520, 2005
|Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas|
T Hida, Y Yatabe, H Achiwa, H Muramatsu, K Kozaki, S Nakamura, ...
Cancer research 58 (17), 3761-3764, 1998
|Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American …|
NI Lindeman, PT Cagle, DL Aisner, ME Arcila, MB Beasley, EH Bernicker, ...
Journal of Thoracic Oncology 13 (3), 323-358, 2018
|Reduced expression of Dicer associated with poor prognosis in lung cancer patients|
Y Karube, H Tanaka, H Osada, S Tomida, Y Tatematsu, K Yanagisawa, ...
Cancer science 96 (2), 111-115, 2005
|Analysis of epidermal growth factor receptor gene mutation in patients with non–small cell lung cancer and acquired resistance to gefitinib|
T Kosaka, Y Yatabe, H Endoh, K Yoshida, T Hida, M Tsuboi, H Tada, ...
Clinical Cancer Research 12 (19), 5764-5769, 2006
|Hepatocyte growth factor induces gefitinib resistance of lung adenocarcinoma with epidermal growth factor receptor–activating mutations|
S Yano, W Wang, QI Li, K Matsumoto, H Sakurama, T Nakamura, H Ogino, ...
Cancer research 68 (22), 9479-9487, 2008
|Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer|
T Mitsudomi, Y Yatabe
Cancer science 98 (12), 1817-1824, 2007
|Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer|
T Mitsudomi, Y Yatabe
The FEBS journal 277 (2), 301-308, 2010
|A common BIM deletion polymorphism mediates intrinsic resistance and inferior responses to tyrosine kinase inhibitors in cancer|
KP Ng, AM Hillmer, CTH Chuah, WC Juan, TK Ko, ASM Teo, ...
Nature medicine 18 (4), 521-528, 2012
|Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer|
SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ...
Nature genetics 45 (4), 371-384, 2013
|PD-L1 immunohistochemistry comparability study in real-life clinical samples: results of blueprint phase 2 project|
MS Tsao, KM Kerr, M Kockx, MB Beasley, AC Borczuk, J Botling, ...
Journal of Thoracic Oncology 13 (9), 1302-1311, 2018
|Genome-wide association studies identify four ER negative–specific breast cancer risk loci|
M Garcia-Closas, FJ Couch, S Lindstrom, K Michailidou, MK Schmidt, ...
Nature genetics 45 (4), 392-398, 2013